dorzolamide and Cardiovascular-Diseases

dorzolamide has been researched along with Cardiovascular-Diseases* in 3 studies

Trials

1 trial(s) available for dorzolamide and Cardiovascular-Diseases

ArticleYear
Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
    American journal of ophthalmology, 2007, Volume: 144, Issue:2

    To evaluate the intercurrent factors for the development of open-angle glaucoma (OAG) in ocular hypertensive patients who were enrolled in the European Glaucoma Prevention Study (EGPS).. Randomized, double masked, controlled clinical trial.. setting: Multicenter. study population: A total of 1,077 patients fulfilled a series of inclusion criteria, including intraocular pressure (IOP) 22 to 29 mm Hg, normal and reliable visual fields (VFs) and normal optic disks. intervention: Treatment with dorzolamide or placebo. main outcome measures: Glaucoma-related VF or optic disk changes. Clinical data were collected every six months during a five-year follow-up. Proportional hazards models were used to identify the factors that during follow-up (intercurrent factors) were associated with the development of OAG.. In multivariate analyses, adjusting for treatment arms and baseline predictive factors, mean follow-up IOP reduction (hazard ratio [HR] 0.89, 95% confidence intervals [CI] 0.80 to 0.98), mean follow-up IOP (HR 1.12, 95% CI 1.03 to 1.22), area under the curve of IOP (mm Hg per year) (HR 1.09, 95% CI 1.06 to 1.12), disk hemorrhages (HR 1.97, 95% CI 1.21 to 3.22), and use of systemic diuretics (HR 2.41, 95% CI 1.12 to 5.19) were associated with the development of OAG. Baseline central corneal thickness, vertical cup/disk ratio, vertical cup/disk ratio asymmetry, and pattern standard deviation remained statistically significant.. These results suggest the need for future investigations to better elucidate the role of systemic diuretics in the development of OAG, because IOP and disk hemorrhages have already been shown to be important intercurrent factors in the Ocular Hypertension Treatment Study (OHTS) and Early Manifest Glaucoma Trial (EMGT).

    Topics: Antihypertensive Agents; Cardiovascular Diseases; Confidence Intervals; Cornea; Diuretics; Double-Blind Method; Europe; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Optic Disk; Prevalence; Proportional Hazards Models; Retinal Hemorrhage; Retrospective Studies; Risk Factors; Sulfonamides; Thiophenes; Time Factors; Treatment Outcome

2007

Other Studies

2 other study(ies) available for dorzolamide and Cardiovascular-Diseases

ArticleYear
Intercurrent factors associated with the development of open-angle glaucoma in the European glaucoma prevention study.
    American journal of ophthalmology, 2008, Volume: 145, Issue:1

    Topics: Antihypertensive Agents; Cardiovascular Diseases; Diabetes Complications; Europe; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Prevalence; Risk Factors; Sulfonamides; Thiophenes; Treatment Outcome

2008
Diuretics, placebos, and the European glaucoma prevention study.
    American journal of ophthalmology, 2007, Volume: 144, Issue:2

    Topics: Antihypertensive Agents; Cardiovascular Diseases; Diuretics; Europe; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Optic Disk; Prevalence; Randomized Controlled Trials as Topic; Retinal Hemorrhage; Risk Factors; Sulfonamides; Thiophenes

2007